AD313 + Atomoxetine (SEED)

· Apnimed

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD313 + Atomoxetine (SEED), covering 2023-04-07 to 2023-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED) [Phase 1, Phase 2]